Anindita Chanda

Anindita Chanda

Auto-generated profile, based on publicly available information

Anindita Chanda

Department of Internal Medicine University of Connecticut School of Medicine Farmington Connecticut USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
AVAmanda R. Vest
Amanda R. Vest
LPLori Lyn Price
Lori Lyn Price
ACAnindita Chanda
Anindita Chanda
BSBenjamin A. Sweigart
Benjamin A. Sweigart
JCJoronia Chery
Joronia Chery
ESEdward Saltzman
Edward Saltzman
Background: Severe cardiac cachexia or malnutrition are commonly considered relative contraindications to left ventricular assist device (LVAD) implantation, but post‐LVAD prognosis for patients with cachexia is uncertain. Methods and Results: Intermacs (Interagency Registry for Mechanically Assisted Circulatory Support) 2006 to 2017 was queried for the preimplantation variable cachexia/malnutrition. Cox proportional hazards modeling examined the relationship between cachexia and LVAD outcomes. Of 20 332 primary LVAD recipients with available data, 516 (2.54%) were reported to have baseline cachexia and had higher risk baseline characteristics. Cachexia was associated with higher mortality during LVAD support (unadjusted hazard ratio [HR], 1.36 [95% CI, 1.18–1.56]; P <0.0001), persisting after adjustment for baseline characteristics (adjusted HR, 1.23 [95% CI, 1.0–1.42]; P =0.005). Mean weight change at 12 months was +3.9±9.4 kg. Across the cohort, weight gain ≥5% during the first 3 months of LVAD support was associated with lower mortality (unadjusted HR, 0.90 [95% CI, 0.84–0.98]; P =0.012; adjusted HR, 0.89 [95% CI, 0.82–0.97]; P =0.006). Conclusions: The proportion of LVAD recipients recognized to have cachexia preimplantation was low at 2.5%. Recognized cachexia was independently associated with higher mortality during LVAD support. Early weight gain ≥5% was independently associated with lower mortality during subsequent LVAD support.

25 February 2025 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
ACAnindita Chanda
Anindita Chanda
DGDamla C. Gonullu‐Rotman
Damla C. Gonullu‐Rotman
MEMohammed Elsadany
Mohammed Elsadany
SSStephanie Saucier
Stephanie Saucier
ISIrina Sobol
Irina Sobol
OAOmar A. Abdul‐Rahman
Omar A. Abdul‐Rahman